Physician profile
Anan Tawil
NPI 1538450135
$7,892.24
in general payments reported to CMS, 2019-2025
30 companies · $2,425 in 2025
The $2,425 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $147 · 2021: $542 · 2022: $3,000 · 2023: $931 · 2024: $691 · 2025: $2,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467 · Travel and Lodging: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,466.82 |
| Travel and Lodging | $1,580.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,076.14 | 2021-2025 | Venaseal, Endurant Iis |
| Cordis US Corp. | $1,244.52 | 2024-2025 | Precise Pro Rx, Angioguard |
| W. L. Gore & Associates, INC. | $690.52 | 2023-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Stryker Corporation | $648.36 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Endologix LLC | $532.34 | 2025 | Endocross Device, Torus Stent Graft System |
| Globus Medical, INC. | $463.61 | 2021 | |
| Nuvasive, INC. | $196.45 | 2023 | Pulse |
| Cook Medical LLC | $179.80 | 2024-2025 | Zenith Spiral-Z, Zenith, Zenith Alpha |
| Penumbra, INC. | $127.00 | 2019 | |
| Medtronic Vascular, INC. | $123.97 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $73.71 | 2023 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $58.24 | 2024 | Optimizer |
| Bard Peripheral Vascular, INC. | $48.80 | 2019-2021 | |
| Shockwave Medical, INC | $46.15 | 2022-2024 | Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter |
| Silk Road Medical, INC. | $44.10 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $36.09 | 2023 | Amvuttra |
| Innovation Technologies INC | $30.11 | 2022 | |
| Tactile Systems Technology INC | $28.48 | 2024 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $27.50 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.17 | 2023 | |
| Janssen Pharmaceuticals, INC | $24.26 | 2021 | |
| Cvrx, INC. | $23.79 | 2023 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $23.77 | 2024 | Arcalyst |
| Inari Medical, INC. | $19.93 | 2021 | |
| Smith+Nephew, INC. | $19.09 | 2025 | Stravix Pl |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.49 | 2024 | Lifevest |
| Boston Scientific Corporation | $17.17 | 2019 | |
| Inspire Medical Systems, INC. | $16.32 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $14.70 | 2024 | Verquvo |
| Amgen INC. | $13.66 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anan Tawil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.